News | Press Releases

---

March 8, 2013

TOSHIBA LAUNCHES NEW CARDIAC ULTRASOUND SYSTEMS AT ACC

Aplio 500 CV and Aplio 300 CV Designed to Improve Cardiac Diagnoses  

 SAN FRANCISCO, March 8, 2013 – To help clinicians more accurately and efficiently diagnose cardiovascular disease, Toshiba America Medical Systems, Inc. introduces the Aplio^TM 500 and Aplio 300 CV ultrasound systems. Compact and easy-to-use, Aplio 500 CV and Aplio 300 CV deliver exceptional image quality and advanced technologies to improve patient diagnoses and treatment.

Both the Aplio 500 and 300 CV are the systems of choice for all premium 2D cardiac exams and feature Toshiba’s 2D Wall Motion Tracking technology, which provides stunning visualization and quantitative analysis of myocardial wall motion with unrivaled accuracy and reproducibility. With on-board cardiac quantification measurements in all directions (radial, circumferential, 2D rotation and longitudinal), the Aplio CV systems are designed to get the most comprehensive information anytime and anywhere in the hospital, right at the patient’s bedside. 

Additional cardiac-specific technologies include Tissue Enhancement, Advanced Dynamic Flow™, Lateral Gain Controls, Tissue Doppler, Stress Echo, Flex-M Mode and Auto IMT. Both systems are easy to use, with superior ergonomics and a smaller footprint, making them easier to maneuver for greater patient access and improved workflow.

 “Aplio 500 and 300 CV provide picture-perfect images with unprecedented resolution, and deliver clinical data faster and more reliably,” said Tomohiro Hasegawa, director, Ultrasound Business Unit, Toshiba. “Combined with 2D Wall Motion Tracking, physicians can conduct the best bedside cardiac exams and have access to the most comprehensive quantification measurements (strain, strain rates or ejection fraction) on-board the systems and in just three simple clicks.”

Toshiba will showcase Aplio 500 CV and Aplio 300 CV at this year’s American College of Cardiology (ACC) annual meeting in San Francisco, March 9 – 11, 2013 (Booth #5733, North Hall).

About Toshiba America Medical Systems, Inc.

With headquarters in Tustin, Calif., Toshiba America Medical Systems (TAMS) markets, sells, distributes and services radiology and cardiovascular systems, including CT, MR, ultrasound, X-ray and cardiovascular equipment, and coordinates clinical diagnostic imaging research for all modalities in the United States. For more information, visit the TAMS website at www.medical.toshiba.com.

About Toshiba Medical Systems Corporation

Toshiba Medical Systems Corporation is a leading worldwide provider of medical diagnostic imaging systems and comprehensive medical solutions, such as CT, X-ray and vascular, ultrasound, nuclear medicine and MRI systems, as well as information systems for medical institutions. Toshiba Medical Systems Corporation has been providing medical products for over 80 years. Toshiba Medical Systems Corporation is a wholly owned subsidiary of Toshiba.

About Toshiba

Toshiba is a world-leading diversified manufacturer, solutions provider and marketer of advanced electronic and electrical products and systems. Toshiba Group brings innovation and imagination to a wide range of businesses: digital products, including LCD TVs, notebook PCs, retail solutions and MFPs; electronic devices, including semiconductors, storage products and materials; industrial and social infrastructure systems, including power generation systems, smart community solutions, medical systems and escalators & elevators; and home appliances.

Toshiba was founded in 1875, and today operates a global network of more than 550 consolidated companies, with 202,000 employees worldwide and annual sales surpassing 6.1 trillion yen (US$74 billion). Visit Toshiba’s website at www.toshiba.co.jp/index.htm.